CYP2C19 and type 2 diabetes mellitus: In addition, T2D patients have elevated levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) which have been associated with the downregulation of cytochrome P450 (CYP) isoforms CYP3As and CYP2C19 [109].